uMotif's mission is to put patients at the center of clinical research. Designed with patients for patients, the uMotif patient-first eClinical platform powers site-based to fully decentralized clinical, real-world, and post-marketing research. By engaging patients and healthcare professionals, uMotif is trusted by global pharmaceutical companies, biotechs, CROs, and academic institutions to capture large volumes of eCOA/ePRO, symptom, and wearable device data. www.umotif.com
$25M sweet spot round size
2012
$25M
from 2 investors over 1 rounds
uMotif raised $25M on June 25, 2022
Investors: Athyrium Capital Management LP and + 1 Other investor